Managing mitral regurgitation: focus on the MitraClip device

J Trent Magruder,1 Todd C Crawford,1 Joshua C Grimm,1 Joseph L Fredi,2 Ashish S Shah3 1Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, 3Department of Cardiac S...

Full description

Bibliographic Details
Main Authors: Magruder JT, Crawford TC, Grimm JC, Fredi JL, Shah AS
Format: Article
Language:English
Published: Dove Medical Press 2016-04-01
Series:Medical Devices: Evidence and Research
Subjects:
Online Access:https://www.dovepress.com/managing-mitral-regurgitation-focus-on-the-mitraclip-device-peer-reviewed-article-MDER
_version_ 1818982780843851776
author Magruder JT
Crawford TC
Grimm JC
Fredi JL
Shah AS
author_facet Magruder JT
Crawford TC
Grimm JC
Fredi JL
Shah AS
author_sort Magruder JT
collection DOAJ
description J Trent Magruder,1 Todd C Crawford,1 Joshua C Grimm,1 Joseph L Fredi,2 Ashish S Shah3 1Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, 3Department of Cardiac Surgery, Vanderbilt University School of Medicine, Nashville, TN, USA Abstract: Based on the principle of surgical edge-to-edge mitral valve repair (MVR), the MitraClip percutaneous MVR technique has emerged as a minimally invasive option for MVR. This catheter-based system has been widely demonstrated to be safe, although inferior to surgical MVR. Studies examining patients with ≥3+ mitral regurgitation (MR) show that, for all patients treated, freedom from death, surgery, or MR ≥3+ is in the 75%–80% range 1 year following MitraClip implantation. Despite its inferiority to surgical therapy, in high-risk surgical patients, data suggest that the MitraClip system can be employed safely and that it can result in symptomatic improvement in the majority of patients, while not precluding future surgical options. MitraClip therapy also appears to reduce heart failure readmissions in the high-risk cohort, which may lead to an economic benefit. Ongoing study is needed to clarify the impact of percutaneous mitral valve clipping on long-term survival in high-risk populations, as well as its role in other patient populations, such as those with functional MR. Keywords: mitral clips, mitral regurgitation, cardiac surgery, percutaneous, transcatheter
first_indexed 2024-12-20T17:52:40Z
format Article
id doaj.art-bcf5285a7df549128c29d5cbcbbf677b
institution Directory Open Access Journal
issn 1179-1470
language English
last_indexed 2024-12-20T17:52:40Z
publishDate 2016-04-01
publisher Dove Medical Press
record_format Article
series Medical Devices: Evidence and Research
spelling doaj.art-bcf5285a7df549128c29d5cbcbbf677b2022-12-21T19:30:49ZengDove Medical PressMedical Devices: Evidence and Research1179-14702016-04-012016Issue 1536026388Managing mitral regurgitation: focus on the MitraClip deviceMagruder JTCrawford TCGrimm JCFredi JLShah ASJ Trent Magruder,1 Todd C Crawford,1 Joshua C Grimm,1 Joseph L Fredi,2 Ashish S Shah3 1Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, 3Department of Cardiac Surgery, Vanderbilt University School of Medicine, Nashville, TN, USA Abstract: Based on the principle of surgical edge-to-edge mitral valve repair (MVR), the MitraClip percutaneous MVR technique has emerged as a minimally invasive option for MVR. This catheter-based system has been widely demonstrated to be safe, although inferior to surgical MVR. Studies examining patients with ≥3+ mitral regurgitation (MR) show that, for all patients treated, freedom from death, surgery, or MR ≥3+ is in the 75%–80% range 1 year following MitraClip implantation. Despite its inferiority to surgical therapy, in high-risk surgical patients, data suggest that the MitraClip system can be employed safely and that it can result in symptomatic improvement in the majority of patients, while not precluding future surgical options. MitraClip therapy also appears to reduce heart failure readmissions in the high-risk cohort, which may lead to an economic benefit. Ongoing study is needed to clarify the impact of percutaneous mitral valve clipping on long-term survival in high-risk populations, as well as its role in other patient populations, such as those with functional MR. Keywords: mitral clips, mitral regurgitation, cardiac surgery, percutaneous, transcatheterhttps://www.dovepress.com/managing-mitral-regurgitation-focus-on-the-mitraclip-device-peer-reviewed-article-MDERmitral clipsmitral regurgitationcardiac surgerypercutaneous
spellingShingle Magruder JT
Crawford TC
Grimm JC
Fredi JL
Shah AS
Managing mitral regurgitation: focus on the MitraClip device
Medical Devices: Evidence and Research
mitral clips
mitral regurgitation
cardiac surgery
percutaneous
title Managing mitral regurgitation: focus on the MitraClip device
title_full Managing mitral regurgitation: focus on the MitraClip device
title_fullStr Managing mitral regurgitation: focus on the MitraClip device
title_full_unstemmed Managing mitral regurgitation: focus on the MitraClip device
title_short Managing mitral regurgitation: focus on the MitraClip device
title_sort managing mitral regurgitation focus on the mitraclip device
topic mitral clips
mitral regurgitation
cardiac surgery
percutaneous
url https://www.dovepress.com/managing-mitral-regurgitation-focus-on-the-mitraclip-device-peer-reviewed-article-MDER
work_keys_str_mv AT magruderjt managingmitralregurgitationfocusonthemitraclipdevice
AT crawfordtc managingmitralregurgitationfocusonthemitraclipdevice
AT grimmjc managingmitralregurgitationfocusonthemitraclipdevice
AT fredijl managingmitralregurgitationfocusonthemitraclipdevice
AT shahas managingmitralregurgitationfocusonthemitraclipdevice